This consists of three hands-on training workshops in which predoctoral researchers have developed new outreach proposals based on their research, with professional guidance and support.

The accumulation of metabolic products within cardiac cells alters their function and accelerates the deterioration of heart tissue with age.

The proposal focuses on automatic speech analysis as a digital biomarker for the early detection and monitoring of depression.

The network will work in the prevention of cognitive and physical decline, early and digital diagnosis, the development of technologies to support independent living, support for carers and families, as well as new therapies and biomarkers.

A Vall d’Hebron team demonstrates, for the first time, the potential of optical genome mapping to detect genetic alterations associated with this rare disease that are not identified using conventional methods.

On April 18 and 19, the Vall d’Hebron Research Institute (VHIR) will once again join the Science Festival 2026 with a diverse and participatory program focused on health, innovation, and citizen engagement in research.

The donation will enable further characterisation of patients with this rare disease, the identification of new biomarkers and the exploration of innovative therapies.

Under the agreement, IQVIA will preferentially offer Vall d’Hebron clinical studies managed by the company.

The session focused on the scientific, regulatory and clinical challenges of advanced therapy medicinal products, from preclinical research to first-in-human trials.

The initiative will enable young people aged 12 to 18 to collaborate with campus researchers in the design, development and communication of scientific projects, placing patients and families at the centre of the research process.

The Gen Rebelde Foundation has made the first donation of the year to the gene therapy research project for GNB1 encephalopathy.

The study describes the first documented case worldwide of hereditary angioedema transmission through assisted reproduction.

The donation will support a research line focused on understanding the progression of this inflammatory liver disease and improving treatment personalisation.

The recognition highlights the Cuidador Acompañante project, a nursing-led initiative that promotes the active and safe participation of families in the Intensive Care Unit (ICU).

The funds will enable the company to accelerate the preclinical phase and explore the application of its immunotherapy in other types of cancer.

A study led by the Vall d'Hebron Research Institute (VHIR) demonstrates the causal role of air pollution in ventricular arrhythmias and identifies a possible therapeutic strategy based on antioxidants.

The REACH5 study confirms that the efficacy and safety results observed in previous studies are maintained after three years of follow-up.

With women representing 66% of its workforce, the Institute is promoting a new Equality Plan to advance equity in research and leadership.

Researchers from the centre took part in international debates on AI in healthcare, spin-offs emerging from research were presented, and several initiatives linked to VHIR received recognition in the field of entrepreneurship.

In-depth knowledge of tumours helps identify specific alterations and enables the provision of targeted therapies for each patient.

Es tracta del VHTeDades, un espai de dades de salut segur i interoperable que posarà a l'abast de la comunitat científica i assistencial del Campus milions de dades d’alta qualitat.

The study results show that the local presence of IL-1β promotes the development of myeloid cells with an immunosuppressive function.

The charitable initiative created in honor of Pol is supporting a research project aimed at identifying therapeutic targets to treat a rare type of leukemia.

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.